Answers are grounded in this paper and cite their sources.
Using a homologous radioimmunoassay we have compared plasma prolactin concentrations in 49 patients with breast cancer and 39 hospital controls. When a drug history was taken into account no difference was found. In addition we have studied the effect of Stilbestrol in 6 females with advanced breast cancer. Remission of disease has been noted in the face of elevated prolactin levels.
No takes yet. Share an insight, caveat, or question.
Wilson et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: